Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sahin

Showing results (311-320 of 454) with videos related to

Pageof 46
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.
Journal for Immunotherapy of Cancer|March 16, 2021
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cellsStanley Ly, Vivek Anand, Fouad El-Dana, et al.
Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.
Cancer Investigation|March 10, 2010
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapyBanu K Arun, Laura A Granville, Guosheng Yin, et al.
Breast Cancer Research and Treatment|March 27, 2013
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerJames L Murray, Patricia Thompson, Suk Young Yoo, et al.
JAMA Oncology|March 18, 2016
The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After TreatmentElizabeth A Mittendorf, Jose Vila, Susan L Tucker, et al.
Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 19, 2011
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter studyHasmet A Hanagasi, Hakan Gurvit, Pınar Unsalan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancerN Cabioglu, Y Gong, R Islam, et al.
Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.
Pageof 46

Showing results (311-320 of 454) with videos related to

Sort By:
Pageof 46
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.
Journal for Immunotherapy of Cancer|March 16, 2021
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2<sup>+</sup> breast cancer stem-like cellsStanley Ly, Vivek Anand, Fouad El-Dana, et al.
Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.
Cancer Investigation|March 10, 2010
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapyBanu K Arun, Laura A Granville, Guosheng Yin, et al.
Breast Cancer Research and Treatment|March 27, 2013
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerJames L Murray, Patricia Thompson, Suk Young Yoo, et al.
JAMA Oncology|March 18, 2016
The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After TreatmentElizabeth A Mittendorf, Jose Vila, Susan L Tucker, et al.
Pathology Oncology Research : POR|November 3, 2001
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistryF J Esteva, G N Hortobagyi, A A Sahin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 19, 2011
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter studyHasmet A Hanagasi, Hakan Gurvit, Pınar Unsalan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2007
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancerN Cabioglu, Y Gong, R Islam, et al.
Annals of Surgical Oncology|September 19, 2013
Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patientsAbigail S Caudle, Min Yi, Karen E Hoffman, et al.
Pageof 46